NEUROECTODERMAL TUMORS, PRIMITIVE
Clinical trials for NEUROECTODERMAL TUMORS, PRIMITIVE explained in plain language.
Never miss a new study
Get alerted when new NEUROECTODERMAL TUMORS, PRIMITIVE trials appear
Sign up with your email to follow new studies for NEUROECTODERMAL TUMORS, PRIMITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Doctors test virus to fight Kids' brain cancer
Disease control Recruiting nowThis study is testing the safety of an experimental virus therapy called G207 for children and young adults with recurrent or hard-to-treat brain tumors in the cerebellum. The virus is designed to infect and kill cancer cells while sparing healthy ones. Researchers will also test…
Matched conditions: NEUROECTODERMAL TUMORS, PRIMITIVE
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New pill tested for Tough-to-Treat brain cancers
Disease control Recruiting nowThis is the first study in people testing an experimental pill called ONC206 for adults with recurrent brain tumors that have few treatment options. The main goal is to find the highest safe dose and understand the side effects. Researchers will enroll about 102 patients to test …
Matched conditions: NEUROECTODERMAL TUMORS, PRIMITIVE
Phase: PHASE1 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC